Literature DB >> 2345840

Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria.

S Yusuf1, P Held, K K Teo, E R Toretsky.   

Abstract

This paper discusses the various philosophies that influence the selection of patients for entry into randomized controlled trials. Although a number of different and often competing issues have to be considered depending upon the trial, keeping entry criteria simple, wide and at times even flexible is usually preferable. Such a strategy can be a positive virtue by helping to attain the large numbers of patients that are usually needed to reliably detect the sorts of moderate benefits that are plausible, at a reasonable cost and by providing answers that are relevant to many different categories of patients with a particular condition.

Entities:  

Mesh:

Year:  1990        PMID: 2345840     DOI: 10.1002/sim.4780090114

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  19 in total

Review 1.  Randomised controlled trials in cardiovascular medicine: past achievements, future challenges.

Authors:  S Yusuf
Journal:  BMJ       Date:  1999-08-28

Review 2.  Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies.

Authors:  M McKee; A Britton; N Black; K McPherson; C Sanderson; C Bain
Journal:  BMJ       Date:  1999-07-31

3.  Evidence-based medicine: a commentary on common criticisms.

Authors:  S E Straus; F A McAlister
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

Review 4.  Design issues for drug epidemiology.

Authors:  A D McMahon; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

5.  A call for systematic reviews.

Authors:  Victor M Montori; Somnath Saha; Mike Clarke
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

6.  Using medicare data for comparative effectiveness research: opportunities and challenges.

Authors:  Vicki Fung; Richard J Brand; Joseph P Newhouse; John Hsu
Journal:  Am J Manag Care       Date:  2011       Impact factor: 2.229

7.  The Confounding Question of Confounding Causes in Randomized Trials.

Authors:  Jonathan Fuller
Journal:  Br J Philos Sci       Date:  2018-01-22       Impact factor: 3.978

8.  The breast cancer research scandal: addressing the issues.

Authors:  C Weijer
Journal:  CMAJ       Date:  1995-04-15       Impact factor: 8.262

9.  Evaluation of chronic disease self-management programme (CDSMP) for older adults in Hong Kong.

Authors:  W L S Chan; E Hui; C Chan; D Cheung; S Wong; R Wong; S Li; J Woo
Journal:  J Nutr Health Aging       Date:  2011-03       Impact factor: 4.075

Review 10.  The doctor's duty to the elderly patient in clinical trials.

Authors:  Antony Bayer; Mark Fish
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.